Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential candida albicans isolates from a human immunodeficiency virus-infected southern chinese cohort

Journal of Clinical Microbiology

Volumn 39, Issue 9, 2001, Pages 3296-3302

  Samaranayake, Y H ^a   Samaranayake, L P ^a   Pow, E H N ^a   Beena, V T ^a   Yeung, K W S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; DNA; EGG WHITE; FLUCONAZOLE; KETOCONAZOLE; LACTOFERRIN; LYSOZYME; NYSTATIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MALE; NONHUMAN; OROPHARYNX; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; THRUSH;

CANDIDA ALBICANS; HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0034827946     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.9.3296-3302.2001     Document Type: Article

References (62)

1. Antifungal resistance towards the year 2000
2. Longitudinal evaluation of major salivary gland function in HIV-1 infected patients
3. Elevation of salivary antimicrobial proteins following HIV-1 infection
4. Association of lactoferrin with specific granules in rabbit heterophilic leukocytes
5. Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole
6. Comparison of PCR fingerprinting, by random amplification of polymorphic DNA, with other molecular typing methods for Candida albicans
7. Variability in expression of a cell surface determinant on Candida albicans as evidenced by an agglutinating monoclonal antibody
8. Specific and nonspecific immune factors in dental plaque fluid and saliva from young and old populations
9. Lactoferrin concentration in human parotid saliva as measured by an enzyme-linked immunosorbent assay (ELISA)
10. 2+
11. Saliva and salivary gland alterations in HIV infection
12. HIV-related oral disease
13. Lytic action of lysozyme on Candida albicans
14. Salivary defense factors and oral health in patients with common variable immunodeficiency
15. Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: Inhibition by chitin oligosaccharides
16. Comparison of the separation of Candida albicans chromosome-size DNA by pulsedfield gel electrophoresis techniques
17. Characterization of lactoferrin interaction with Streptococcus mutans
18. Genotypic identification and characterization of species and strains within the genus Candida by using random amplified polymorphic DNA
19. Lactoferrin, myeloperoxidase, lysozyme, and eosinophilic cationic protein in exudate in delayed type hypersensitivity
20. Oral colonization, phenotypic, and genotypic profiles of Candida species in irradiated, dentate, xerostomic nasopharyngeal carcinoma survivors
21. Rapid and constant detection of HIV antibody response in saliva of HIV-infected patients; selective distribution of anti-HIV activity in the IgG isotype
22. Longitudinal study of parotid saliva in HIV-1 infection
23. Cytomegalovirus presence and salivary composition in acquired immunodeficiency syndrome
24. Fungitoxicity of muramidase, ultrastructural damage to Candida albicans
25. Studies of lactoferrin, the iron-binding protein of secretions
26. Lactoferrin and iron-binding protein in neutrophilic leukocytes
27. Comparative studies of the iron-binding properties of human transferrins
28. Oral Candida albicans from patients infected with the human immunodeficiency virus and characterization of a genetically distinct subgroup of Candida albicans Aust
29. Nonspecific oral immunity in individuals with HIV infection
30. The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin
31. The fungicidal effect of human lactoferrin on Candida albicans and Candida krusei
32. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species
33. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis
34. Lysozyme activity and flow rates of mixed saliva in children, adolescents and adults
35. Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection
36. Correlations between human salivary levels of lysozyme, lactoferrin, salivary peroxidase and secretory immunoglobulin A with different stimulatory states and over time
37. Oral mycoses in human immunodeficiency virus infection: A review
38. A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavity
39. The in vitro lysozyme susceptibility of Candida species cultured in sucrose supplemented media
40. The in vitro lysozyme susceptibility of Candida albicans cultured in carbohydrate-supplemented media
41. The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans
42. Epidemiology of oral candidiasis in HIV-infected patients: Colonization, infection, treatment, and emergence of fluconazole resistance
43. Sialochemistry in human immunodeficiency virus associated salivary, gland disease
44. Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting
45. Evolution and replacement of Candida albicans strains during recurrent vaginitis demonstrated by DNA fingerprinting
46. Switching of Candida albicans during successive episodes of recurrent vaginitis
47. Fungicidal effect of human lactoferrin against Candida albicans
48. Identification of Candida species by randomly amplified polymorphic DNA fingerprinting of colony lysates
49. A comparative study of salivary lysozyme in caries-resistant and caries-susceptible adults
50. Nonimmunoglobulin defense factors in human saliva
51. Salivary lysozyme, lactoferrin and peroxidases. Antibacterial effect on cariogenic bacteria and clinical application in preventive dentistry
52. The in vitro susceptibility of Candida species to lysozyme
53. Salivary lysozyme and related parameters of a predominantly Chinese, HIV-infected cohort in Hong Kong
54. Plasma lactoferrin levels are decreased in end-stage AIDS patients
55. Phenotypes and randomly amplified polymorphic DNA profiles of Candida albicans isolates from root canal infections in a Finnish population
56. Iron and infection
57. Candida albicans in patients with the acquired immunodeficiency syndrome: Absence of a novel or hypervirulent strain
58. In vitro susceptibility of Candida species to lactoferrin
59. Oral defense mechanisms are impaired early in HIV-1 infected patients